Diabetes Research Study
Type-two diabetics are asked to participate in a new research study conducted at UNMC.Photo: Video by kmtv.com
Omaha - Diabetes is the seventh leading cause of death in the United States. For many the pain lasts a lifetime but now there is new hope, right in Omaha.
Ray Mayfield starts every day the same, with his coffee and his medication. "I live with it like it's nothing to me, it doesn't slow me down," says Mayfield who's lived with diabetes since 2009.
Type-two diabetes kills tens of thousands of Americans every year. Mayfield lives in pain but he's changed his lifestyle to be a survivor. "I have seen the worst of it, I have also felt the worst of it," he hopes a new study can help.
The new study, called "grade", will determine what the best treatment combination drugs is for diabetics. Many type-two diabetics already take a drug called Metformin. Over a five year span, the study will determine what combination of drugs reacts best with metformin. "Maybe drug combination "A" is going to treat your diabetes much longer than drug combination "B", "says University of Nebraska Medical Center Doctor Cyrus Desouza, who is leading the study in Omaha.
Some of the medications that will be used are new within the last ten years and haven't been used in combination. Unlike previous large studies, researchers hope to gather data about how diabetes medication reacts with different races of people and how to individualize therapy. "There are very few studies that have been done on African Americans or Hispanics," says Doctor Desouza.
Mayfield cannot participate in the study because he has other medical conditions. He hopes others will participate, so one day he will live pain free, "I can't throw a football, I can barely bowl, I guess I'm only entitled to walking."
To qualify for the five year study, type-two diabetes must be the only medical condition a patient is suffering from. Participants must be living with the disease for less than five years and must be at least 19 to qualify. People of all races are encouraged to apply.
All study related medication and doctor visits will be free and participants will receive a stipend.
Contact Grace Rodriguez at the UNMC Diabetes Center at email@example.com or call 402-559-6244.
Contact Deb Romberger at the VA Clinical Research Unit at firstname.lastname@example.org or 402-995-3541.